Canada markets close in 4 hours 18 minutes

Takeda Pharmaceutical Co Ltd (TKD.BE)

Berlin - Berlin Delayed Price. Currency in EUR
Add to watchlist
24.27+0.03 (+0.12%)
As of 08:08AM CEST. Market open.
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2024-03-31
2023-03-31
2022-03-31
2021-03-31
2020-03-31
Total Revenue
4,263,762,000
4,263,762,000
4,027,478,000
3,569,006,000
3,197,812,000
-
Cost of Revenue
1,426,678,000
1,426,678,000
1,244,072,000
1,106,846,000
994,308,000
-
Gross Profit
2,837,084,000
2,837,084,000
2,783,406,000
2,462,160,000
2,203,504,000
-
Operating Expenses
Research Development
729,924,000
729,924,000
633,325,000
526,087,000
455,833,000
-
Selling General and Administrative
1,053,819,000
1,053,819,000
997,309,000
886,361,000
875,663,000
-
Total Operating Expenses
2,527,183,000
2,527,183,000
2,237,985,000
1,936,840,000
1,805,437,000
-
Operating Income or Loss
309,901,000
309,901,000
545,421,000
525,320,000
398,067,000
-
Interest Expense
119,535,000
119,535,000
116,973,000
122,432,000
130,806,000
-
Total Other Income/Expenses Net
-116,645,000
-116,645,000
-46,945,000
-99,274,000
106,321,000
-
Income Before Tax
52,791,000
52,791,000
375,090,000
302,571,000
366,235,000
-
Income Tax Expense
-91,406,000
-91,406,000
58,052,000
72,405,000
-9,936,000
-
Income from Continuing Operations
144,197,000
144,197,000
317,038,000
230,166,000
376,171,000
-
Net Income
144,067,000
144,067,000
317,017,000
230,059,000
376,005,000
-
Net Income available to common shareholders
144,067,000
144,067,000
317,017,000
230,059,000
376,005,000
-
Basic EPS
123.18
-
204.29
147.14
240.72
28.41
Diluted EPS
121.35
-
201.94
145.87
238.96
28.25
Basic Average Shares
1,557,376
-
1,551,809
1,563,501
1,562,006
1,557,204
Diluted Average Shares
1,576,431
-
1,569,872
1,577,169
1,573,537
1,566,204